262 related articles for article (PubMed ID: 21383592)
1. Rosiglitazone regulates c-reactive protein-induced inflammatory responses via glucocorticoid receptor-mediated inhibition of p38 mitogen-activated protein kinase-toll-like receptor 4 signal pathway in vascular smooth muscle cells.
Liu N; Liu JT; Ji YY; Lu PP
J Cardiovasc Pharmacol; 2011 Mar; 57(3):348-56. PubMed ID: 21383592
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
[TBL] [Abstract][Full Text] [Related]
3. PPARalpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway.
Ji YY; Liu JT; Liu N; Wang ZD; Liu CH
Biochem Pharmacol; 2009 Nov; 78(9):1186-97. PubMed ID: 19576184
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 4 signaling mediates inflammatory activation induced by C-reactive protein in vascular smooth muscle cells.
Liu N; Liu J; Ji Y; Lu P
Cell Physiol Biochem; 2010; 25(4-5):467-76. PubMed ID: 20332628
[TBL] [Abstract][Full Text] [Related]
5. PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway.
Ji Y; Liu J; Wang Z; Liu N; Gou W
Lab Invest; 2009 Aug; 89(8):887-902. PubMed ID: 19451898
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
[TBL] [Abstract][Full Text] [Related]
7. PPARγ agonist rosiglitazone ameliorates LPS-induced inflammation in vascular smooth muscle cells via the TLR4/TRIF/IRF3/IP-10 signaling pathway.
Ji Y; Liu J; Wang Z; Li Z
Cytokine; 2011 Sep; 55(3):409-19. PubMed ID: 21700474
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways.
Lin FY; Chen YH; Tasi JS; Chen JW; Yang TL; Wang HJ; Li CY; Chen YL; Lin SJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2630-7. PubMed ID: 17008589
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein triggers inflammatory responses partly via TLR4/IRF3/NF-κB signaling pathway in rat vascular smooth muscle cells.
Liu N; Liu JT; Ji YY; Lu PP
Life Sci; 2010 Sep; 87(11-12):367-74. PubMed ID: 20670634
[TBL] [Abstract][Full Text] [Related]
10. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
[TBL] [Abstract][Full Text] [Related]
11. The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation.
Lin FY; Chen YH; Lin YW; Tsai JS; Chen JW; Wang HJ; Chen YL; Li CY; Lin SJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2622-9. PubMed ID: 16990552
[TBL] [Abstract][Full Text] [Related]
12. Emodin Inhibits Homocysteine-Induced C-Reactive Protein Generation in Vascular Smooth Muscle Cells by Regulating PPARγ Expression and ROS-ERK1/2/p38 Signal Pathway.
Pang X; Liu J; Li Y; Zhao J; Zhang X
PLoS One; 2015; 10(7):e0131295. PubMed ID: 26131983
[TBL] [Abstract][Full Text] [Related]
13. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth.
Gouni-Berthold I; Berthold HK; Weber AA; Seul C; Vetter H; Sachinidis A
Exp Clin Endocrinol Diabetes; 2001; 109(4):203-9. PubMed ID: 11453032
[TBL] [Abstract][Full Text] [Related]
15. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production.
Lee GL; Chang YW; Wu JY; Wu ML; Wu KK; Yet SF; Kuo CC
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2751-60. PubMed ID: 22995520
[TBL] [Abstract][Full Text] [Related]
16. Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: role of ERK1/2, p38 MAPK, and NF-kappaB.
Lin CC; Lin WN; Wang WJ; Sun CC; Tung WH; Wang HH; Yang CM
Cardiovasc Res; 2009 Jun; 82(3):522-31. PubMed ID: 19233864
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein induces TNF-α secretion by p38 MAPK-TLR4 signal pathway in rat vascular smooth muscle cells.
Liu N; Liu J; Ji Y; Lu P; Wang C; Guo F
Inflammation; 2011 Aug; 34(4):283-90. PubMed ID: 20676742
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone increases matrix production and quenches inflammation: studies in human cells.
Solini A; Santini E; Madec S; Nannipieri M; Bonotti A; Cuccato S; Ferrannini E
Diabetes Metab Res Rev; 2008; 24(3):197-204. PubMed ID: 17922475
[TBL] [Abstract][Full Text] [Related]
19. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
20. 15-deoxy-Delta12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells.
Hovsepian E; Penas F; Goren NB
Shock; 2010 Jul; 34(1):60-7. PubMed ID: 19997048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]